Facebook Instagram

Meta Ads for Longevity, Peptide Therapy & IV Treatment Centers. A center that releases a durability Meta program anticipating med-spa economics or TRT-style patient volume burns budget and concludes incorrectly that "Meta doesn't benefit durability." Meta works; the program just needs to respect what's actually hard regarding the group.

We report on enrolled method clients (revenue), material engagement depth (leading indicator), and FDA-status compliance protection (risk-management metric). Audience-building has to depend a lot more heavily on lookalikes from existing individuals (HIPAA-carefully sourced) and on interest-adjacency from closely-associated podcasters and brand names.

The audience is biohacker-educated, reflexively ad-skeptical, and convinced most longevity advertising is serpent oil. Biohacker target markets have been trained to mark down sleek health advertisements. Counterintuitively, a phone-shot 8-minute service provider explainer consistently outperforms a $20k studio-produced imaginative spot on this target market.

Meta has broad health-and-Wellness Meta advertising guide rate of interest targeting, functional-medicine-adjacent targeting, biohacking discussed occasionally, but "longevity" as a purchaser category is badly indexed. Enlisted procedure individuals, content-engagement deepness, and compliance insurance coverage.

The TRT Meta rules (taking on national brand names, symptom-adjacent creative) do not apply since there are no dominant national durability brands running Meta ads-- the channel is actually under-saturated. We develop 90-180 day retargeting home windows with creative turning-- different carrier, various method, various angle every 3-4 weeks-- so the audience sees 10-15 substantive touches before the seek advice from CTA ever terminates.